Luo Y - Search Results

1

Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.

Zhao W, Li J, Chen MM, Luo Y, Ju Z, Nesser NK, Johnson-Camacho K, Boniface CT, Lawrence Y, Pande NT, Davies MA, Herlyn M, Muranen T, Zervantonakis IK, von Euw E, Schultz A, Kumar SV, Korkut A, Spellman PT, Akbani R, Slamon DJ, Gray JW, Brugge JS, Lu Y, Mills GB, Liang H. Zhao W, et al. Among authors: luo y. Cancer Cell. 2020 Dec 14;38(6):829-843.e4. doi: 10.1016/j.ccell.2020.10.008. Epub 2020 Nov 5. Cancer Cell. 2020. PMID: 33157050 Free PMC article.

2

Convergent Usage of Amino Acids in Human Cancers as A Reversed Process of Tissue Development.

Luo Y, Liang H. Luo Y, et al. Genomics Proteomics Bioinformatics. 2022 Feb;20(1):147-162. doi: 10.1016/j.gpb.2021.08.004. Epub 2021 Sep 4. Genomics Proteomics Bioinformatics. 2022. PMID: 34492340 Free PMC article.

3

RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells.

Peng X, Luo Y, Li H, Guo X, Chen H, Ji X, Liang H. Peng X, et al. Among authors: luo y. PLoS Genet. 2022 Mar 30;18(3):e1010130. doi: 10.1371/journal.pgen.1010130. eCollection 2022 Mar. PLoS Genet. 2022. PMID: 35353808 Free PMC article.

4

Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma.

Zhou Z, Chen MM, Luo Y, Mojumdar K, Peng X, Chen H, Kumar SV, Akbani R, Lu Y, Liang H. Zhou Z, et al. Among authors: luo y. Cancer Cell. 2022 Nov 14;40(11):1324-1340.e8. doi: 10.1016/j.ccell.2022.10.012. Epub 2022 Nov 3. Cancer Cell. 2022. PMID: 36332624 Free PMC article.

5

Cancer Cells Employ the Most Prolific RNA Editors: A Closer Look at the Single-Cell Level.

Luo Y, Liang H. Luo Y, et al. Cancer Res. 2023 Feb 3;83(3):351-353. doi: 10.1158/0008-5472.CAN-22-3537. Cancer Res. 2023. PMID: 36734079

6

A mast cell-thermoregulatory neuron circuit axis regulates hypothermia in anaphylaxis.

Bao C, Chen O, Sheng H, Zhang J, Luo Y, Hayes BW, Liang H, Liedtke W, Ji RR, Abraham SN. Bao C, et al. Among authors: luo y. Sci Immunol. 2023 Mar 17;8(81):eadc9417. doi: 10.1126/sciimmunol.adc9417. Epub 2023 Mar 17. Sci Immunol. 2023. PMID: 36930731 Free PMC article.

7

Single-cell dissection of tumor microenvironmental response and resistance to cancer therapy.

Luo Y, Liang H. Luo Y, et al. Trends Genet. 2023 Oct;39(10):758-772. doi: 10.1016/j.tig.2023.07.005. Epub 2023 Aug 30. Trends Genet. 2023. PMID: 37658004 Review.

8

Loss of ADAR1 in macrophages in combination with interferon gamma suppresses tumor growth by remodeling the tumor microenvironment.

Lin W, Luo Y, Wu J, Zhang H, Jin G, Guo C, Zhou H, Liang H, Xu X. Lin W, et al. Among authors: luo y. J Immunother Cancer. 2023 Nov;11(11):e007402. doi: 10.1136/jitc-2023-007402. J Immunother Cancer. 2023. PMID: 37935565 Free PMC article.

9

Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors.

Kim C, Wang XD, Liu Z, Hao J, Wang S, Li P, Zi Z, Ding Q, Jang S, Kim J, Luo Y, Huffman KE, Pal Choudhuri S, Del Rio S, Cai L, Liang H, Drapkin BJ, Minna JD, Yu Y. Kim C, et al. Among authors: luo y. Sci Adv. 2024 Jan 19;10(3):eadh2579. doi: 10.1126/sciadv.adh2579. Epub 2024 Jan 19. Sci Adv. 2024. PMID: 38241363 Free PMC article.

10

Cxxc finger protein 1 maintains homeostasis and function of intestinal group 3 innate lymphoid cells with aging.

Shen X, Gao X, Luo Y, Xu Q, Fan Y, Hong S, Huang Z, Liu X, Wang Q, Chen Z, Wang D, Lu L, Wu C, Liang H, Wang L. Shen X, et al. Among authors: luo y. Nat Aging. 2023 Aug;3(8):965-981. doi: 10.1038/s43587-023-00453-7. Epub 2023 Jul 10. Nat Aging. 2023. PMID: 37429951

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27,178 results

Search Page